Oklahoma SB2021 bans direct-to-consumer pharmaceutical advertising, with civil and criminal penalties.
Oklahoma SB2021 prohibits pharmaceutical companies from engaging in direct-to-consumer advertising of prescription drugs within the state or primarily directed at Oklahoma residents. Prohibited activities include broadcasting advertisements via television, radio, online streaming services, billboards, email, text messaging, or social media. Exceptions include educational materials distributed by health care providers, internal communications within health care organizations, communications required by federal or state law, and brand-neutral public health campaigns.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.